R&D Why it is more important than ever to optimise and innovate ... Rare disease research is vital to improve the lives of hundreds of millions of people worldwide.
R&D How the Life Sciences Innovative Manufacturing Fund can boos... Since the turn of the decade, the pharmaceuticals industry has dealt with supply chain challenges caused by both the pandemic and global conflict.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
